SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 80 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $10,182,000 | -21.4% | 2,189,700 | +28.9% | 1.48% | -15.5% |
| Q3 2021 | $12,957,000 | +11.6% | 1,698,107 | +41.7% | 1.75% | +7.0% |
| Q2 2021 | $11,608,000 | +31.8% | 1,197,976 | +12.5% | 1.64% | -4.5% |
| Q1 2021 | $8,807,000 | +30.3% | 1,064,933 | +75.6% | 1.71% | +69.9% |
| Q3 2020 | $6,760,000 | +1177.9% | 606,298 | +111.0% | 1.01% | +358.6% |
| Q1 2020 | $529,000 | +475.0% | 287,386 | +957.4% | 0.22% | +746.2% |
| Q4 2019 | $92,000 | – | 27,178 | -67.9% | 0.03% | – |
| Q4 2018 | $0 | -100.0% | 84,536 | +388.6% | 0.00% | -100.0% |
| Q2 2017 | $35,000 | -78.4% | 17,300 | -17.6% | 0.00% | -66.7% |
| Q3 2016 | $162,000 | -88.6% | 20,986 | -91.7% | 0.01% | -91.9% |
| Q2 2016 | $1,421,000 | -30.4% | 253,805 | -33.2% | 0.07% | -27.5% |
| Q1 2016 | $2,043,000 | -21.8% | 379,800 | +26.6% | 0.10% | -29.2% |
| Q4 2015 | $2,613,000 | +86.4% | 300,000 | +79.6% | 0.14% | +148.3% |
| Q3 2015 | $1,402,000 | -22.0% | 167,064 | -24.8% | 0.06% | -49.6% |
| Q4 2013 | $1,798,000 | – | 222,026 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
| KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
| AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
| TRUST CO OF VERMONT | 204 | $19 | 0.00% |
| SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
| Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
| Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |